Follow-Up in Neuroendocrine Neoplasms: Can Chromogranin A Be the Cofounder?

#1735

Introduction: Chromogranin A continues to be one of the most valuable markers for neuroendocrine tumors (NETs) however, it has several limitations.

Aim(s): Describe the difficulties associated to the follow-up in a NET patient.

Materials and methods: Case report of a patient with a midgut NET.

Conference: 14th Annual ENETSConcerence (2017)

Presenting Author:

Authors: Martins D, Batista C, Velez A, Macário F, Carrilho F,

Keywords: Neuroendocrine, follow-up, CgA, renal disease,